Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance

Influenza and other Respiratory Viruses

Volumn 9, Issue 4, 2015, Pages 179-190

  Huang, Qiu Sue ^a   Turner, Nikki ^b   Baker, Michael G ^c   Williamson, Deborah A ^a,c,d   Wong, Conroy ^e   Webby, Richard ^f   Widdowson, Marc Alain ^g   Aley, Debbie ^h   Bandaranayake, Don ^h   Bissielo, Ange ^h   Davey, Kirstin ^h   Duque, Jazmin ^h   Grant, Cameron C ^h   Gross, Diane ^h   Lawrence, Shirley ^h   Mackereth, Graham ^h   McArdle, Barbara ^h   McArthur, Colin ^h   Pierse, Nevil ^h   Radke, Sarah ^h   Roberts, Sally ^h   Seeds, Ruth ^h   Taylor, Susan ^h   Thomas, Paul ^h   Thompson, Mark ^h   Todd, Angela ^h   Trenholme, Adrian ^h   Wood, Tim ^h   Wong, Sook San ^h   more..

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^e Department of General Surgery   (New Zealand)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h NONE

Author keywords

Disease burden; Epidemiology; Immunology; Influenza; Risk factors; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

CASE MANAGEMENT; CHILD HOSPITALIZATION; CONSULTATION; DISEASE SURVEILLANCE; DRUG EFFICACY; GENERAL PRACTICE; HEALTH CARE POLICY; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STUDY DESIGN; VIRUS STRAIN; GENETICS; HEALTH SURVEY; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MEDICAL RESEARCH; VIROLOGY;

BIOMEDICAL RESEARCH; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; POPULATION SURVEILLANCE;

EID: 84930793982     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12315     Document Type: Review

References (83)

1. WHO. Report of the Review Committee on the Functioning of the International Health Regulations (2005) in relation to Pandemic (H1N1) 2009. 2011. Available at http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_10-en.pdf (Accessed 11 April 2014).
2. Fineberg HV. Pandemic preparedness and response-lessons from the H1N1 influenza of 2009. N Engl J Med 2014; 370:1335-1342.
3. Huang QS, Bandaranayake D, Lopez LD et al. Surveillance for the 2009 pandemic influenza A (H1N1) virus and seasonal influenza viruses - New Zealand, 2009. MMWR 2009; 58:918-921.
4. Huang QS, Lopez LD, McCallum L, Adlam B. Influenza surveillance and immunisation in New Zealand, 1997-2006. Influenza Other Respir Viruses 2008; 2:139-145.
5. Huang QS, Lopez L, Adlam B. Influenza surveillance in New Zealand in 2005. N Z Med J 2007; 120:U2581.
6. Baker MG, Wilson N, Huang QS et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009; 14: pii:19319.
7. Baker MG, Barnard LT, Kvalsvig A et al. Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study. Lancet 2012; 379:1112-1119.
8. Kuster SP, Shah PS, Coleman BL et al. Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis. PLoS ONE 2011; 6:e26239.
9. Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011; 205:10-18.
10. Nair H, Brooks WA, Katz M et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011; 378:1917-1930.
11. SAGE_Working_Group. Background paper on influenza vaccines and immunization. 2012. http://www.who.int/immunization/sage/meetings/2012/April/1_Background_Paper_Mar26_v13_cleaned.pdf?ua=1. (Accessed 23 April 2015).
12. Thompson WW, Shay DK, Weintraub E et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-1340.
13. Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-186.
14. Zambon M. Assessment of the burden of influenza in children. Lancet 2011; 378:1897-1898.
15. Cauchemez S, Horby P, Fox A et al. Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog 2012; 8:e1003061.
16. Hayward AC, Fragaszy EB, Bermingham A et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med 2014; 2:445-454.
17. Nicoll A, Ciancio BC, Lopez Chavarrias V et al. Influenza-related deaths-available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe. Euro Surveill 2012; 17:pii: 20162.
18. Riley S, Kwok KO, Wu KM et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med 2011; 8:e1000442.
19. Ali SA, Williams JV, Chen Q et al. Human metapneumovirus in hospitalized children in Amman, Jordan. J Med Virol 2010; 82:1012-1016.
20. Cilla G, Onate E, Perez-Yarza EG, Montes M, Vicente D, Perez-Trallero E. Viruses in community-acquired pneumonia in children aged less than 3 years old: high rate of viral coinfection. J Med Virol 2008; 80:1843-1849.
21. Drews AL, Atmar RL, Glezen WP, Baxter BD, Piedra PA, Greenberg SB. Dual respiratory virus infections. Clin Infect Dis 1997; 25:1421-1429.
22. Richard N, Komurian-Pradel F, Javouhey E et al. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J 2008; 27:213-217.
23. Semple MG, Cowell A, Dove W et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 2005; 191:382-386.
24. De Paulis M, Gilio AE, Ferraro AA et al. Severity of viral coinfection in hospitalized infants with respiratory syncytial virus infection. J Pediatr 2011; 87:307-313.
25. Huang JJ, Huang TY, Huang MY et al. Simultaneous multiple viral infections in childhood acute lower respiratory tract infections in southern Taiwan. J Trop Pediatr 1998; 44:308-311.
26. Huguenin A, Moutte L, Renois F et al. Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system. J Med Virol 2012; 84:979-985.
27. Peacey M, Hall RJ, Sonnberg S et al. Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009. Emerg Infect Dis 2010; 16:1618-1620.
28. Renois F, Talmud D, Huguenin A et al. Rapid detection of respiratory tract viral infections and coinfections in patients with influenza-like illnesses by use of reverse transcription-PCR DNA microarray systems. J Clin Microbiol 2010; 48:3836-3842.
29. Martin ET, Kuypers J, Wald A, Englund JA. Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children. Influenza Other Respir Viruses 2012; 6:71-77.
30. Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA 2013; 309:275-282.
31. Joseph C, Togawa Y, Shindo N. Bacterial and viral infections associated with influenza. Influenza Other Respir Viruses 2013; 7(Suppl 2):105-113.
32. Russell CA, Jones TC, Barr IG et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008; 26(Suppl 4):D31-D34.
33. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis. Lancet Infect Dis 2012; 12:36-44.
34. Nelson JC, Jackson LM, Weiss NS, Jackson LA. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 2009; 62:687-694.
35. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. The Cochrane database of systematic reviews 2007; 8:CD001269.
36. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013; 31:3104-3109.
37. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31:2165-2168.
38. Lang P-O, Govind S, Mitchell WA, Siegrist C-A, Aspinall R. Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Res Rev 2011; 10:389-395.
39. Nichol KL. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine 2009; 27:6305-6311.
40. Turner N, Pierse N, Bissielo A et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Vaccine 2014; 32:3687-3693.
41. Turner N, Pierse N, Bissielo A et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations and primary care visits in Auckland, New Zealand in 2013. Euro Surveill 2014; 19: pii=20884.
42. Bandaranayake D, Huang QS, Bissielo A et al. Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic. PLoS ONE 2010; 5:e13211.
43. Monsalvo AC, Batalle JP, Lopez MF et al. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 2011; 17:195-199.
44. Chan JF, To KK, Tse H et al. The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation. Clin Vaccine Immunol 2011; 18:305-310.
45. Gordon CL, Johnson PD, Permezel M et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis 2010; 50:672-678.
46. Bermejo-Martin JF, Martin-Loeches I, Rello J et al. Host adaptive immunity deficiency in severe pandemic influenza. Crit Care 2010; 14:R167.
47. Keynan Y, Malik S, Fowke KR. The role of polymorphisms in host immune genes in determining the severity of respiratory illness caused by pandemic H1N1 influenza. Public Health Genomics 2013; 16:9-16.
48. Mertz D, Kim TH, Johnstone J et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013; 347:f5061.
49. Bandaranayake D, Jacobs M, Baker M et al. The second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-October 2010. Euro Surveill 2011; 16: pii: 19788.
50. Louie JK, Acosta M, Samuel MC et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011; 52:301-312.
51. The ANZIC Influenza Investigators. Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand. N Engl J Med 2009; 361:1925-1934.
52. O'Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010; 182:39-44.
53. Mosby LG, Rasmussen SA, Jamieson DJ. 2009 Pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011; 205:10-18.
54. Baker M, McNicholas A, Garrett N et al. Household crowding a major risk factor for epidemic meningococcal disease in Auckland children. Pediatr Infect Dis J 2000; 19:983-990.
55. Jaine R, Baker M, Venugopal K. Acute rheumatic fever associated with household crowding in a developed country. Pediatr Infect Dis J 2011; 30:315-319.
56. Baker M, Das D, Venugopal K, Howden-Chapman P. Tuberculosis associated with household crowding in a developed country. J Epidemiol Community Health 2008; 62:715-721.
57. Papenburg J, Baz M, Hamelin ME et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis 2010; 51:1033-1041.
58. Cowling BJ, Chan KH, Fang VJ et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-2184.
59. Sloan C, Moore ML, Hartert T. Impact of pollution, climate, and sociodemographic factors on spatiotemporal dynamics of seasonal respiratory viruses. Clin Transl Sci 2011; 4:48-54.
60. Huang QS, Baker MG, McArthur C et al. Implementing hospital-based surveillance for severe acute respiratory infections (SARI) caused by influenza and other respiratory pathogens in New Zealand. Western Pac Surveill Response J 2014; 5:23-30.
61. WHO. WHO Interim Global Epidemiological Surveillance Standards for Influenza. 2012. Available at: http://www.who.int/influenza/resources/documents/INFSURVMANUAL.pdf (Accessed 22 Feburary 2014).
62. PAHO-CDC. Generic protocol for influenza surveillance. 2006. Available at: http://www.paho.org/English/AD/DPC/CD/flu-snl-gpis.pdf (Accessed 3 March 2011).
63. WHO. WHO Global Epidemiological Surveillance Standards for Influenza. 2014. Available at: http://www.who.int/influenza/resources/documents/influenza_surveillance:manual/en/index.html (Accessed 22 Feburary 2014.
64. WHO-Europe. WHO Regional Office for Europe guidance for influenza surveillance in humans. 2009. Available at: http://www.euro.who.int/__data/assets/pdf_file/0020/90443/E92738.pdf (Accessed 16 March 2014).
65. Gupta V, Dawood FS, Rai SK et al. Validity of clinical case definitions for influenza surveillance among hospitalized patients: results from a rural community in North India. Influenza Other Respir Viruses 2013; 7:321-329.
66. Murray EL, Khagayi S, Ope M et al. What are the most sensitive and specific sign and symptom combinations for influenza in patients hospitalized with acute respiratory illness? Results from western Kenya, January 2007-July 2010. Epidemiol Infect 2013; 141:212-222.
67. Nachtnebel M, Greutelaers B, Falkenhorst G et al. Lessons from a one-year hospital-based surveillance of acute respiratory infections in Berlin- comparing case definitions to monitor influenza. BMC Public Health 2012; 12:245.
68. Azziz-Baumgartner E, Alamgir AS, Rahman M et al. Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010. Bull World Health Organ 2012; 90:12-19.
69. Fuller JA, Summers A, Katz MA et al. Estimation of the national disease burden of influenza-associated severe acute respiratory illness in Kenya and Guatemala: a novel methodology. PLoS ONE 2013; 8:e56882.
70. Simmerman JM, Lertiendumrong J, Dowell SF et al. The cost of influenza in Thailand. Vaccine 2006; 24:4417-4426.
71. Yu H, Huang J, Huai Y et al. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012. Influenza Other Respir Viruses 2014; 8:53-65.
72. Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:31-40.
73. Dawood FS, Fiore A, Kamimoto L et al. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J Pediatr 2010; 157:808-814.
74. Dao CN, Kamimoto L, Nowell M et al. Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States. J Infect Dis 2010; 202:881-888.
75. Chiu SS, Chan KH, Chen H et al. Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis 2009; 49:1016-1021.
76. Huang QS, Roberts S, McArthur C et al. High influenza hospitalisations lead to extension of free influenza vaccination to young children. N Z Public Health Surveill Rep 2013; 11:5-6.
77. Dawood FS, Iuliano AD, Reed C et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012; 12:687-695.
78. Simonsen L, Spreeuwenberg P, Lustig R et al. Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med 2013; 10:e1001558.
79. Huang QS, Turner N, Cameron J et al. Influenza-associated primary care consultations and hospitalisations show contrasting socio-demorgraphic patterns. N Z Public Health Surveill Rep 2014; 12:4-5.
80. Kovacs G, Kalo Z, Jahnz-Rozyk K et al. Medical and economic burden of influenza in the elderly population in central and eastern European countries. Hum Vaccin Immunother 2014; 10:428-440.
81. Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA. Influenza cost and cost-effectiveness studies globally-a review. Vaccine 2013; 31:5339-5348.
82. Gaunt ER, Harvala H, McIntyre C, Templeton KE, Simmonds P. Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model. J Clin Virol 2011; 52:215-221.
83. Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 1997; 315:1060-1064.